Question 1

Am I eligible for this trial based on my cancer type and previous treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor clinical trial (NCT06472245). Contact the study team or your healthcare provider for specific answers.

Question 2

How does OSE2101 compare to docetaxel in terms of side effects and effectiveness?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor clinical trial (NCT06472245). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of OSE2101?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor clinical trial (NCT06472245). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor clinical trial (NCT06472245). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests will be done to determine if I qualify for this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor clinical trial (NCT06472245). Contact the study team or your healthcare provider for specific answers.

Question 6

How will participating in this trial affect my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor clinical trial (NCT06472245). Contact the study team or your healthcare provider for specific answers.

What this study is about